Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (1958)	10/1/1997 8:59:00 AM
From: Henry Niman	of 6136

John, I don't have any position in AGPH, but I did predict resistance would develop in spite of the good news that came out when PI results started to some in. I think that the UCSF report is strong evidence that resistance is just a matter of time. I don't think that anyone would say that the 47% who have "undectable" levels of HIV are actually free of the virus. Its simple biology coupled with mutations which increase with time. Its much more obvious and quicker with higher viral loads, but the AP report on the UCSF study indicated that "most" of the 53% who have detectable virus now did initially move into the "undectable" category after starting PI's. "Most patients responded dramatically. Their virus levels dropped so low they could not be found on standard tests. But since then, the virus has returned to detectable levels in 53 percent."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next